GlobeNewswire by notified

AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors

Share

LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today the appointment of Sean McDonald to its Board of Directors which will now comprise five members.

“We are pleased to welcome Sean to the board and believe his experience building and leading healthcare organizations and securing funding for early-stage companies will be invaluable to our mission at AccuStem,” said Wendy Blosser, Chief Executive Officer and board member of AccuStem.

Sean joins the AccuStem board while serving as the CEO of Ocugenix, a therapeutics company focused on the development and commercialization of therapies for ocular diseases caused by excessive fibrosis and blood vessels in the eye.

Sean served as a director at Aethon, a healthcare technology business that automates hospital logistics, from 2006 to 2017. From 2015 to 2016 Mr. McDonald was a venture partner with Adams Capital Management, a venture capital firm specializing in early-stage applied technology investments. Prior to that, from 2001 to 2014, Sean served as the CEO of Precision Therapeutics, one of the first biotechnology companies to marry breakthroughs in understanding of cancer biology and the use of machine learning with the goal of developing products that would help cancer patients get the most effective cancer treatment. From 2002 to 2008, Sean was also a director on the board of Respironics where he was a member of the audit and compensation committees leading up to its $5.1 billion acquisition by Phillips.

Sean started his career in healthcare by founding Automated Healthcare which was one of the first companies to develop systems for automating the dispensing and administration of medication in hospital pharmacies. Mr. McDonald grew the organization from its inception to over 1,000 employees and oversaw the building of market access, clinical, product development and sales and marketing organizations. Automated Healthcare was ultimately acquired by McKesson Corporation where Sean became President of the automation group.

“I am delighted to join the AccuStem team at such a pivotal time for the company,” said Sean McDonald. “As genomic testing serves an increasingly important role in oncology care it will be critical that companies are able to commercialize novel tests that address unanswered clinical questions. With my background in scaling companies from inception to exit, and past working experience with the current leadership team, I believe I will be able to help the company execute its growth strategy and achieve its long term goals.”

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness”, we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making. For more information, please visit www.accustem.com.

Media Contact:
Jeff Fensterer, Chief Operations Officer
Phone: 415-640-6010
Email: jeff@accustem.com

Investor Contact:
Wendy Blosser, Chief Executive Officer
Email: investors@accustem.com


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Sportradar and Oddin.gg Ink AV Betting Agreement to Elevate and Expand Esports Reach28.3.2024 09:00:00 CET | Press release

PRAGUE, Czech Republic and ST. GALLEN, Switzerland, March 28, 2024 (GLOBE NEWSWIRE) -- Sportradar (NASDAQ: SRAD) and Oddin.gg, an award-winning B2B betting-solutions provider for esports, today announced they have entered into a multi-year strategic partnership to offer audiovisual streaming of Oddin’s exclusive esports content to Sportradar’s betting operator clients around the world. The deal will support Oddin.gg’s growth ambitions in the expanding global esports market, whose betting turnover was estimated to be €83 billion in 2023. It will extend the reach of Oddin.gg’s official competition content by leveraging Sportradar’s market leading position as an AV betting provider. Sportradar’s global network of 900+ betting operator clients will benefit from the opportunity to offer greater volume and a wider variety of live streamed esports events to their customers, increasing opportunities for engagement with existing and new betting markets. The partnership also paves the way for fu

Municipality Finance issues a EUR 50 million tap under its MTN programme28.3.2024 09:00:00 CET | Press release

Municipality Finance Plc Stock exchange release 28 March 2024 at 10:00 am (EET) Municipality Finance issues a EUR 50 million tap under its MTN programme On 3 April 2024 Municipality Finance Plc issues a new tranche in an amount of EUR 50 million to an existing benchmark issued on 26 April 2023. With the new tranche, the aggregate nominal amount of the benchmark is EUR 1.30 billion. The maturity date of the benchmark is 29 July 2030. The benchmark bears interest at a fixed rate of 3.125 % per annum. The new tranche is issued under MuniFin’s EUR 45 billion programme for the issuance of debt instruments. The offering circular, the supplemental offering circular and final terms of the notes are available in English on the company's website at www.munifin.fi/investor-relations. MuniFin has applied for the new tranche to be admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. The public trading is expected to commence on 3 April 2024. The existing notes in the se

PunaMusta Media on toteuttanut medialiiketoiminnan kaupan Keskisuomalaiselle28.3.2024 09:00:00 CET | Press release

PUNAMUSTA MEDIA OYJ PÖRSSITIEDOTE 28.3.2024 KLO 10.00 PunaMusta Media Oyj on tänään 28.3.2024 toteuttanut tytäryhtiöidensä Sanomalehti Karjalainen Oy:n, Karelia Viestintä Oy:n ja PunaMusta Paikallismediat Oy:n koko osakekantojen myynnin Keskisuomalainen Oyj:lle. Medialiiketoiminta siirtyy Keskisuomalaisen omistukseen 1.4.2024. Samalla PunaMusta Media-konserni luopuu medialiiketoiminnastaan. PunaMusta Media Oyj tiedotti 31.1.2024 allekirjoittaneensa kauppakirjan medialiiketoiminnan myynnistä Keskisuomalainen Oyj:lle. Kaupan täytäntöönpano oli ehdollinen Kilpailu- ja kuluttajaviraston hyväksynnälle. Kilpailu- ja kuluttajavirasto ilmoitti hyväksyneensä kaupan 6.3.2024. Osakekauppojen velaton kauppahinta on 8,5 miljoonaa euroa, joka maksettiin kaupan toteuttamishetkellä. PunaMusta Media kirjaa konsernissa arvioidun myyntivoiton noin 10,2 miljoonaa euroa. Medialiiketoiminnan ulkoinen liikevaihto vuonna 2023 oli 17,6 miljoonaa euroa (19,0 miljoonaa euroa vuonna 2022), ja liiketulos oli 0,6 m

Invitation to Aspo's Capital Markets Day 202428.3.2024 09:00:00 CET | Press release

Aspo Plc Press Release March 28, 2024, at 10:00 Invitation to Aspo’s Capital Markets Day 2024 Aspo is pleased to invite investors, analysts and media representatives to Aspo's Capital Markets Day 2024. The event will be held in Helsinki and online. Date: Tuesday, May 14, 2024 Place: Allas Sea Pool Restaurant, Katajanokanlaituri 2A, Helsinki Time (EET): 9:15 Registrations 9:30 Presentations 12:00 Lunch from 12:30 Ship tours Aspo’s CEO Rolf Jansson together with members of the Group Executive Committee will host the event and provide current information on the company's business operations, strategy, and financial development. The presentations will be held in English. Each presentation will be followed by a Q&A session, where participants can post questions also through the webcast platform. Guests who are present at the event venue in Helsinki may also visit m/s Electramar, which is the first vessel of AtoB@C Shipping’s batch of 12 new electric hybrid vessels. The vessel will be moored

KH Group’s Annual Report 2023 published28.3.2024 08:45:00 CET | Press release

KH Group Plc Stock exchange release 28 March 2024 at 9:45 am EET KH Group’s Annual Report 2023 published KH Group has published its Annual Report for 2023 today. The Annual Report includes the Board of Directors’ Report, Financial Statements, Auditor’s Report as well as the Corporate Governance Statement and the Governing Bodies’ Remuneration Report. The Financial Statements are also published as an xHTML file in Finnish language in accordance with European Single Electronic Format (ESEF) reporting requirements. In line with the ESEF requirements, the Group’s primary statements and notes have been labelled with XBRL tags. The Annual Report, Corporate Governance Statement and the Governing Bodies’ Remuneration Report as well as the xHTML file are available on the Company’s website at www.khgroup.com and attached to this release. KH GROUP PLC FURTHER INFORMATION: CEO Lauri Veijalainen, tel. +358 46 876 1648 DISTRIBUTION: Nasdaq Helsinki Ltd Main media www.khgroup.com Sievi Capital is now

HiddenA line styled icon from Orion Icon Library.Eye